Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 25.8B | 22.7B | 23.6B | 16.4B |
Cost of revenue | 13.1B | 12.2B | 13.0B | 8.5B |
Gross profit | 12.7B | 10.5B | 10.6B | 7.9B |
Operating expense | ||||
Research & development | 6.5B | 5.9B | 5.0B | 2.8B |
Selling general and admin | 2.8B | 2.4B | 2.3B | 1.4B |
Other operating expenses | -48M | -34M | -102M | -12M |
Operating income | 2.1B | 401M | 1.3B | 3.6B |
Non operating interest income | ||||
Income | 182M | 206M | 65M | 8M |
Expense | 92M | 106M | 88M | 34M |
Other income expense | -187M | -9M | -57M | 47M |
Pretax income | 2.0B | 492M | 1.2B | 3.7B |
Tax provision | 381M | -346M | -122M | 513M |
Net income | 1.6B | 854M | 1.3B | 3.2B |
Basic EPS | 1.0 | 0.5 | 0.9 | 2.6 |
Diluted EPS | 1 | 0.5 | 0.8 | 2.6 |
Basic average shares | 1.8B | 1.7B | 1.6B | 1.3B |
Diluted average shares | 1.8B | 1.7B | 1.6B | 1.3B |
EBITDA | 5.4B | 4.1B | 5.5B | 4.2B |
Net income from continuing op. | 1.6B | 854M | 1.3B | 3.2B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |